First in Human Clinical Investigation of the FIRE1 System in Heart Failure Patients (FUTURE-HF)

Exclusion Criteria

• •Significant comorbidity that would interfere with the ability to safely complete the clinical investigation protocol
• •Patients with an estimated Glomerular Filtration Rate (eGFR) \< 30 ml/min
• •Patients with IVC filter placement in situ, abnormal IVC or femoral venous anatomy or known congenital malformation or absence of IVC or occlusive or free-floating thrombus in the IVC
• •Patients with implantable ventricular assist device (LVAD, RVAD, BiVAD) in situ
• •Patients with Cardiovascular Implantable Electronic Device (CIED) implanted ≤ 3 months prior to enrolment
• •Patients with conditions associated with occlusion of the IVC, iliac or common femoral veins (e.g. venous leg ulcers)